OncoBayes
CompanyUnited Kingdom
OncoBayes develops one asset, preclinical (OB-001 in cancer). Mostly small molecule; based in the United Kingdom.
- 1
- Asset
- Furthest stage
- Preclinical
- 0
- Trials
- 0
- Signals
Pipeline
1Overcomes ADC resistance and penetrates the blood-brain barrier to target tumors
Preclinical, Small molecule, cancer, oncology
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Similar companies6